ResearcherCedars-Sinai Medical CenterActive in the last 2 years

Murtaza Ahmed

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5039999848. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2024: 1 paper

Papers 1

A case of adenosquamous pancreatic cancer with a KRAS G12C mutation with an exceptional response to immunotherapy. Co-author DOI 10.18632/oncotarget.28659 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Andrew Eugene Hendifar · 1 shared paper, 2024 · strength 0.28
- Paper A case of adenosquamous pancreatic cancer with a KRAS G12C mutation with an exceptional response to immunotherapy. DOI 10.18632/oncotarget.28659 ↗
Brent K. Larson · 1 shared paper, 2024 · strength 0.28
- Paper A case of adenosquamous pancreatic cancer with a KRAS G12C mutation with an exceptional response to immunotherapy. DOI 10.18632/oncotarget.28659 ↗
Nilofer Saba Azad · 1 shared paper, 2024 · strength 0.28
- Paper A case of adenosquamous pancreatic cancer with a KRAS G12C mutation with an exceptional response to immunotherapy. DOI 10.18632/oncotarget.28659 ↗
Arsen Osipov · 1 shared paper, 2024 · strength 0.28
- Paper A case of adenosquamous pancreatic cancer with a KRAS G12C mutation with an exceptional response to immunotherapy. DOI 10.18632/oncotarget.28659 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.